2015 AACC

Recently Approved Biomarkers of Acute Kidney Injury (AKI)-72214 (Room Georgia World Congress Center - B305)

After this symposium participants should be able to: 1) describe the pathophysiology of insulin-like growth-factor binding protein 7 (IGFBP7) and tissue inhibitor of metalloproteinases (TIMP-2); 2) define the RIFLE and AKIN criteria for AKI ; 3) describe how biomarkers are validated; and 4) describe the analytical performance of new assays for AKI.